Literature DB >> 26168364

The One Year Fate of Iron Oxide Coated Gold Nanoparticles in Mice.

Jelena Kolosnjaj-Tabi1,2, Yasir Javed3, Lénaic Lartigue1,3, Jeanne Volatron1, Dan Elgrabli1, Iris Marangon1, Giammarino Pugliese4, Benoit Caron5, Albert Figuerola4, Nathalie Luciani1, Teresa Pellegrino4, Damien Alloyeau3, Florence Gazeau1.   

Abstract

Safe implementation of nanotechnology and nanomedicine requires an in-depth understanding of the life cycle of nanoparticles in the body. Here, we investigate the long-term fate of gold/iron oxide heterostructures after intravenous injection in mice. We show these heterostructures degrade in vivo and that the magnetic and optical properties change during the degradation process. These particles eventually eliminate from the body. The comparison of two different coating shells for heterostructures, amphiphilic polymer or polyethylene glycol, reveals the long lasting impact of initial surface properties on the nanocrystal degradability and on the kinetics of elimination of magnetic iron and gold from liver and spleen. Modulation of nanoparticles reactivity to the biological environment by the choice of materials and surface functionalization may provide new directions in the design of multifunctional nanomedicines with predictable fate.

Entities:  

Keywords:  aging; biodistribution; degradation; elimination; gold nanoparticles; heterostructure; iron oxide nanoparticles; nanotoxicity

Mesh:

Substances:

Year:  2015        PMID: 26168364     DOI: 10.1021/acsnano.5b00042

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  40 in total

1.  Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies.

Authors:  Ruiping Zhang; Kai Cheng; Alexander L Antaris; Xiaowei Ma; Min Yang; Sindhuja Ramakrishnan; Guifeng Liu; Alex Lu; Hongjie Dai; Mei Tian; Zhen Cheng
Journal:  Biomaterials       Date:  2016-07-02       Impact factor: 12.479

Review 2.  Facilitating Translational Nanomedicine via Predictive Safety Assessment.

Authors:  Vahid Mirshafiee; Wen Jiang; Bingbing Sun; Xiang Wang; Tian Xia
Journal:  Mol Ther       Date:  2017-04-13       Impact factor: 11.454

3.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Authors:  Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; César Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C W Chan; Pere Santamaria
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

Review 4.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

5.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

6.  Biodegradable Gold Nanoclusters with Improved Excretion Due to pH-Triggered Hydrophobic-to-Hydrophilic Transition.

Authors:  Elizabeth M Higbee-Dempsey; Ahmad Amirshaghaghi; Matthew J Case; Mathilde Bouché; Johoon Kim; David P Cormode; Andrew Tsourkas
Journal:  J Am Chem Soc       Date:  2020-04-21       Impact factor: 15.419

7.  Unexpected intracellular biodegradation and recrystallization of gold nanoparticles.

Authors:  Alice Balfourier; Nathalie Luciani; Guillaume Wang; Gerald Lelong; Ovidiu Ersen; Abdelali Khelfa; Damien Alloyeau; Florence Gazeau; Florent Carn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-18       Impact factor: 11.205

Review 8.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

9.  One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.

Authors:  Raziye Mohammadpour; Darwin L Cheney; Jason W Grunberger; Mostafa Yazdimamaghani; Jolanta Jedrzkiewicz; Kyle J Isaacson; Marina A Dobrovolskaia; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2020-05-25       Impact factor: 9.776

10.  DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells.

Authors:  Francesca J Nicholls; Matthew W Rotz; Harmanvir Ghuman; Keith W MacRenaris; Thomas J Meade; Michel Modo
Journal:  Biomaterials       Date:  2015-11-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.